Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Active- and Vehicle-Controlled Study to Compare the Efficacy and Safety of Products S2G6T-1, S2G6T-2, S2G6T-3 and S2G6T-4 in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Conditions
Interventions
S2G6T-1
S2G6T-2
+2 more
Locations
19
United States
TCR Medical Corporation
San Diego, California, United States
University Clinical Trials, Inc.
San Diego, California, United States
Tampa Bay Medical Research
Clearwater, Florida, United States
Tory Sullivan, MD, PA
North Miami Beach, Florida, United States
Park Avenue Dermatology
Orange Park, Florida, United States
Mid Atlantic Research for Health
Baltimore, Maryland, United States
Start Date
September 1, 2016
Primary Completion Date
October 1, 2017
Completion Date
October 1, 2017
Last Updated
November 18, 2020
NCT07245667
NCT00233493
NCT03129321
NCT03897257
NCT00804193
NCT04203342
Lead Sponsor
Sol-Gel Technologies, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions